MedPath

NEUPRO 2, 4, 6, 8 MG/24 H PARCHE TRANSDERMICO

NEUPRO 2, 4, 6, 8 MG/24 H PARCHE TRANSDERMICO

Pending
Register Number

05331013

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Jun 27, 2006

Dosage Form

PARCHE TRANSDÉRMICO

Route: VÍA TRANSDÉRMICA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number05331013
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (1)

ROTIGOTINAActive
Quantity: 0,45 mg
Name: ROTIGOTINA

ATC CLASSIFICATION (3)

N04B
N04BC
N04BC09

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.